about
Stem cells as cellular vehicles for gene therapy against glioblastomaOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyProgress and problems with the use of suicide genes for targeted cancer therapyPotent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine KinaseSuicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells.Current status of gene therapy for brain tumors.Improving the safety of cell therapy products by suicide gene transferInhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide geneAn Enterovirus-Like RNA Construct for Colon Cancer Suicide Gene Therapy.Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapyTherapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.Gene therapy for malignant glioma.Mycoplasmas and cancer: focus on nucleoside metabolismUPRT, a suicide-gene therapy candidate in higher eukaryotes, is required for Drosophila larval growth and normal adult lifespan.Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approachSuperparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking.Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors.Dual-modality imaging demonstrates the enhanced antitumoral effect of herpes simplex virus-thymidine kinase/ganciclovir plus gemcitabine combination therapy on cholangiocarcinoma.Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104.Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidaseRecent advances and future of immunotherapy for glioblastoma.Suicide Gene Therapy for Cancer - Current Strategies.Strategies in gene therapy for glioblastoma.Adenovirus: the first effective in vivo gene delivery vectorInhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway.Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir.Targeted breast cancer therapy by harnessing the inherent blood group antigen immune system.Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer-The Case for Combined Delivery?Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling.Requisites for successful theranostics with radionuclide-based reporter gene imaging.Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.Gene-directed enzyme prodrug therapy.Protein engineering: a new frontier for biological therapeutics.Current status of clinical trials assessing oncolytic virus therapy for urological cancers.
P2860
Q26771835-55C4073A-90EE-4968-8796-778E333988F8Q26998111-ED74F08A-6B50-44E7-A92A-CA0E2B1D0D9DQ28262370-2C01915B-48D2-461E-9EB2-10AFE811D9C9Q28550404-54EC41AE-E75C-43B6-8868-EF4C6A474BF1Q33604560-AB87621F-EE4E-4FA4-9263-D94C0396B8A8Q33635315-469EC7D4-DE77-4246-B289-D4B2F4C75F71Q34318157-6B17745C-261B-4BD3-AA54-46B0124779C0Q34453846-3F5110F7-4D75-4BD7-9212-4581703679D4Q34459849-9A8A8365-30FC-4043-B344-4056CA2AEDF6Q34478571-5DD85DE8-1FA1-4AB9-B5B5-8B45BEFD74F8Q34576976-4374ECA6-E3F6-4187-846A-145C7958AE63Q35082459-5ACA6825-BBAE-4D55-82AE-504086524CADQ35176800-0265F265-02BD-4091-957C-42A36A0A1289Q35673628-90C59AB7-A04D-4123-B02C-0908497CBD5CQ35728840-F1930CCB-66F8-474D-A8F1-037419A08D5AQ35953327-CC1AF179-2C9B-433D-879D-F7A782DEC8A1Q36035112-6D0977F4-ABFD-4A3A-94A5-23A475DC24DEQ36510497-B1ACABB3-58EB-4EA6-B339-0DEB720FF51CQ36530795-710991DD-B8B4-4869-B141-584459D7E0A6Q37001522-7EAC86D8-C575-4CF2-A08D-ADB15F6C7DB2Q37134623-9823822B-FA19-4BDF-9CFB-590D4589194EQ37184187-92BD685F-532C-4927-A33B-23F8B5F67875Q37217739-33AE8C36-BFB3-40D8-918E-CC72D5A05814Q37238908-04F1C038-7704-443A-BA64-677273D16835Q37239071-76CEA106-29D7-4ADF-B319-C0935BCBDF41Q37347017-286E83E9-B4F5-4070-959A-425BBD009262Q37420576-845652D3-DB9D-4FDD-8AE0-6760EF88A3ECQ37508260-40D7B0D9-FC8C-4049-8C24-5A22DC97B1F6Q37579567-A80FDD39-D0CB-42F0-8693-056AFB7048E5Q37593962-8D380E83-89B9-4474-BDF6-0D99DFEC7EF1Q37662190-8341D7F7-BC99-4D40-860A-5DEFD9C1B0C9Q37684212-9AE8D494-F606-4A82-ABCE-07F4D7F99AC4Q37716490-22F8CE85-6F60-4578-92EC-10B5F266D2BAQ37724113-8A522E0C-5D7B-400A-BB53-6A895B2E28FCQ38177279-C8AEEE26-39F6-429B-8DBD-FA0BC456D1E1Q38177892-C7FEE84B-E081-4455-AEAA-2A60A504F343Q38218786-2C20E84A-8907-4BA5-BA4C-64937AB328FCQ38262019-5F6BED29-7969-4AB7-8230-130D84420211Q38286271-6E9D9410-76C7-4C36-8999-B46AFEEA7FB5Q38741837-58D7699B-6151-454B-A4A7-7DD8C18EF2F6
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Suicide gene therapy in cancer: where do we stand now?
@ast
Suicide gene therapy in cancer: where do we stand now?
@en
Suicide gene therapy in cancer: where do we stand now?
@nl
type
label
Suicide gene therapy in cancer: where do we stand now?
@ast
Suicide gene therapy in cancer: where do we stand now?
@en
Suicide gene therapy in cancer: where do we stand now?
@nl
prefLabel
Suicide gene therapy in cancer: where do we stand now?
@ast
Suicide gene therapy in cancer: where do we stand now?
@en
Suicide gene therapy in cancer: where do we stand now?
@nl
P50
P921
P1433
P1476
Suicide gene therapy in cancer: where do we stand now?
@en
P2093
Georges Carle
P304
P356
10.1016/J.CANLET.2012.05.023
P407
P577
2012-05-24T00:00:00Z